title: [Hyperdense areal in the putamen after intra-arterial medialysis: contrast media extravasation or hemorrhage?].
authors.affiliation: Aachen, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Möller-Hartmann
authors.forename: T
authors.initials: T
authors.lastname: Krings
authors.forename: M
authors.initials: M
authors.lastname: Mull
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D002533:Cerebral Angiography; D002536:Cerebral Arteries; D003937:Diagnosis, Differential; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000000981:diagnostic imaging*; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005500:Follow-Up Studies; D006429:Hemiplegia / Q000209:etiology; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007269:Injections, Intra-Arterial; D020767:Intracranial Thrombosis / Q000150:complications / Q000188:drug therapy*; D010960:Plasminogen Activators / Q000008:administration & dosage / Q000627:therapeutic use; D011699:Putamen; D020146:Putaminal Hemorrhage / Q000000981:diagnostic imaging*; D015912:Thrombolytic Therapy / Q000009:adverse effects; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006493:Heparin; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator